InspireMD, Inc.
Symbol: NSPR (NASDAQ)
2.81
▲ (0.54%) 0.015
Company Description:
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.
Key Stats
- Today's Open: $2.68
- Today's High: $2.88
- Today's Low: $2.68
- Today's Volume: 36.06K
- Yesterday Close: $2.79
- Yesterday High: $2.9199
- Yesterday Low: $2.43
- Yesterday Volume: 889.79K
- Last Min Volume: 5
- Last Min High: $2.805
- Last Min Low: $2.805
- Last Min VWAP: $2.805
Company Profile
- Name: InspireMD, Inc.
- Website: https://www.inspiremd.com
- Listed Date: 1997-08-22
- Location: MIAMI, FL
- Market Status: Active
- CIK Number: 0001433607
- SIC Code: 3841
- SIC description: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
- Market Cap: $85.47M
- Round Lot: 100
- Outstanding Shares: 30.64M
- Asset Type: CS
RECENT FILINGS FOR NSPR
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-01 | 3 | View |
| 2025-08-01 | 4 | View |
| 2025-08-01 | 4 | View |
| 2025-08-01 | 4 | View |
| 2025-08-01 | 4 | View |
| 2025-07-31 | 8-K | View |
| 2025-07-23 | 4 | View |
| 2025-07-23 | 4 | View |
| 2025-07-23 | 4 | View |
| 2025-07-23 | 4 | View |
| 2025-07-09 | 8-K | View |
| 2025-06-26 | 3 | View |
| 2025-06-24 | 8-K | View |
| 2025-06-13 | 8-K | View |
| 2025-06-03 | 8-K | View |
| 2025-06-03 | 8-K | View |
| 2025-05-15 | SCHEDULE 13G/A | View |
| 2025-05-15 | SCHEDULE 13G/A | View |
| 2025-05-12 | SCHEDULE 13G/A | View |
| 2025-05-09 | 8-K | View |
Latest News on NSPR